NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
6.95
-0.45 (-6.08%)
At close: Sep 25, 2026, 4:00 PM EDT
7.07
+0.12 (1.71%)
After-hours: Sep 25, 2026, 7:37 PM EDT
NeuroSense Therapeutics Stock Forecast
NRSN's stock price has decreased by -71.98% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, NeuroSense Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $133.33. The average 1-year stock price forecast is 1,818.42% higher than the current stock price, while the lowest is $60 (+763.31%) and the highest is $180 (+2,489.93%).
Price Target: $133.33 (+1,818.42%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NeuroSense Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Initiates $8 | Buy | Initiates | $8 | +15.11% | Sep 3, 2026 |
| Noble Financial | Noble Financial | Buy Reiterates $9 | Buy | Reiterates | $9 | +29.50% | Aug 11, 2026 |
| Roth MKM | Roth MKM | Buy Maintains $3 | Buy | Maintains | $3 | -56.83% | Jun 10, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
2.70M
EPS This Year
-0.39
from -0.44
EPS Next Year
-0.68
from -0.39
EPS and Forward PE are based on non-GAAP adjusted numbers.